These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6215926)

  • 1. Functional aberration of T cell subsets in patients with Behçet's disease.
    Sakane T; Kotani H; Takada S; Tsunematsu T
    Arthritis Rheum; 1982 Nov; 25(11):1343-51. PubMed ID: 6215926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome.
    Victorino RM; Ryan P; Hughes GR; Hodgson HJ
    Clin Exp Immunol; 1982 Apr; 48(1):121-8. PubMed ID: 6211313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behçet's disease: clinical and immunological response to immunosuppressive therapy. A case report.
    Rimon D; Lahat N; Nir E; Cohen L
    Isr J Med Sci; 1985 Jan; 21(1):57-61. PubMed ID: 3156102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A selective loss of T4 cells responding to autologous non-T cells in some patients with Behçet's disease].
    Kotani H; Sakane T; Takada S; Tsunematsu T; Yamana S; Aoi K; Yamamoto M
    Ryumachi; 1983 Feb; 23(1):19-25. PubMed ID: 6223384
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal B cell function in patients with Behçet's disease.
    Suzuki N; Sakane T; Ueda Y; Tsunematsu T
    Arthritis Rheum; 1986 Feb; 29(2):212-9. PubMed ID: 3485432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies.
    Valesini G; Pivetti-Pezzi P; Mastrandrea F; Moncada A; Cuomo M; Natali PG
    Clin Exp Immunol; 1985 Apr; 60(1):55-60. PubMed ID: 3874016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T cell function in patients with Behçet's disease (author's transl].
    Sakane T; Taniguchi Y; Honda M; Katani H
    Arerugi; 1981 Dec; 30(12):1006-12. PubMed ID: 6211160
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspects of lymphocyte function in Behçet's disease.
    Haim S; Mekori T; Sobel JD; Robinson E
    Dermatologica; 1976; 153(1):34-7. PubMed ID: 1086808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of interleukin-2 activity in patients with Behçet's disease. Ability of T cells to produce and respond to interleukin-2.
    Sakane T; Suzuki N; Ueda Y; Takada S; Murakawa Y; Hoshino T; Niwa Y; Tsunematsu T
    Arthritis Rheum; 1986 Mar; 29(3):371-8. PubMed ID: 3083826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte studies in Behçet's syndrome.
    Ahmed AR
    Dermatologica; 1982 Mar; 164(3):175-80. PubMed ID: 6979484
    [No Abstract]   [Full Text] [Related]  

  • 12. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological study of Behcet's disease].
    Kawai K; Masuda K; Akimoto T
    Bull Soc Pathol Exot Filiales; 1978; 71(2):221-6. PubMed ID: 311255
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of suppressor T cell function in patients with rheumatoid arthritis: defects in production of and responsiveness to concanavalin A-induced suppressor T cells.
    Sakane T; Takada S; Murakawa Y; Kotani H; Honda M; Ueda Y
    J Immunol; 1982 Nov; 129(5):1972-7. PubMed ID: 6214584
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte subsets and activated neutrophils in Iraqi patients with Behçet's disease.
    Mousawy KM; Al-Joofy IKh; Muslih RK; Al-Waiz MM
    Adv Exp Med Biol; 2003; 528():269-72. PubMed ID: 12918705
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of the mechanisms of human B-cell activation. IV. Abnormalities at the B-cell level in patients with Behçet's disease].
    Suzuki N; Sakane T; Takada S; Ueda Y; Murakawa Y; Tsunematsu T; Tsuchiya T; Niwa Y
    Ryumachi; 1985 Apr; 25(2):95-102. PubMed ID: 3875902
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of the profile of CD4+ cells in Behçet's disease].
    Sugi N; Nakazawa M; Nakamura S; Minami M; Ohno S
    Nippon Ganka Gakkai Zasshi; 1997 Apr; 101(4):335-40. PubMed ID: 9136573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease.
    Hamzaoui K; Ayed K; Slim A; Hamza M; Touraine J
    Clin Exp Immunol; 1990 Jan; 79(1):28-34. PubMed ID: 2154346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New perspective on Behçet's disease.
    Sakane T
    Int Rev Immunol; 1997; 14(1):89-96. PubMed ID: 9203029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Defects in immunoregulatory circuits activated by concanavalin A in patients with Behçet's disease].
    Takada S; Sakane T; Murakawa Y; Ueda Y; Tsunematsu T
    Arerugi; 1983 Jul; 32(7):393-8. PubMed ID: 6227309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.